| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |